Free Trial
→ Trump's New Dollar (From Porter & Company) (Ad)tc pixel Free UTRS Stock Alerts

Minerva Surgical (UTRS) Competitors

Minerva Surgical logo
Compare

UTRS vs. MOTS, DRTSW, ANZUW, HSCSW, and BEATW

Should you buy Minerva Surgical stock or one of its competitors? MarketBeat compares Minerva Surgical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Minerva Surgical include Motus GI (MOTS), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Heart Test Laboratories (HSCSW), and HeartBeam (BEATW). These companies are all part of the "medical equipment" industry.

How does Minerva Surgical compare to Motus GI?

Motus GI (NASDAQ:MOTS) and Minerva Surgical (NASDAQ:UTRS) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, earnings, media sentiment and analyst recommendations.

20.1% of Motus GI shares are held by institutional investors. 0.3% of Motus GI shares are held by company insiders. Comparatively, 8.5% of Minerva Surgical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Motus GI has a beta of 0.82, indicating that its share price is 18% less volatile than the broader market. Comparatively, Minerva Surgical has a beta of 2.92, indicating that its share price is 192% more volatile than the broader market.

Company Net Margins Return on Equity Return on Assets
Motus GIN/A N/A N/A
Minerva Surgical N/A N/A N/A

Motus GI has higher earnings, but lower revenue than Minerva Surgical. Motus GI is trading at a lower price-to-earnings ratio than Minerva Surgical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Motus GI$319K0.00-$12.87M-$14.69N/A
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A

In the previous week, Motus GI's average media sentiment score of 0.00 equaled Minerva Surgical'saverage media sentiment score.

Company Overall Sentiment
Motus GI Neutral
Minerva Surgical Neutral

Summary

Minerva Surgical beats Motus GI on 4 of the 7 factors compared between the two stocks.

How does Minerva Surgical compare to Alpha Tau Medical?

Minerva Surgical (NASDAQ:UTRS) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation.

In the previous week, Alpha Tau Medical had 1 more articles in the media than Minerva Surgical. MarketBeat recorded 1 mentions for Alpha Tau Medical and 0 mentions for Minerva Surgical. Alpha Tau Medical's average media sentiment score of 1.89 beat Minerva Surgical's score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company Overall Sentiment
Minerva Surgical Neutral
Alpha Tau Medical Very Positive

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

Alpha Tau Medical has lower revenue, but higher earnings than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Summary

Alpha Tau Medical beats Minerva Surgical on 2 of the 3 factors compared between the two stocks.

How does Minerva Surgical compare to Anzu Special Acquisition Corp I?

Minerva Surgical (NASDAQ:UTRS) and Anzu Special Acquisition Corp I (NASDAQ:ANZUW) are both medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, analyst recommendations, dividends, earnings, profitability, valuation, institutional ownership and risk.

Company Net Margins Return on Equity Return on Assets
Minerva SurgicalN/A N/A N/A
Anzu Special Acquisition Corp I N/A N/A N/A

Anzu Special Acquisition Corp I has lower revenue, but higher earnings than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A
Anzu Special Acquisition Corp IN/AN/AN/AN/AN/A

In the previous week, Minerva Surgical's average media sentiment score of 0.00 equaled Anzu Special Acquisition Corp I'saverage media sentiment score.

Company Overall Sentiment
Minerva Surgical Neutral
Anzu Special Acquisition Corp I Neutral

Summary

Minerva Surgical beats Anzu Special Acquisition Corp I on 1 of the 1 factors compared between the two stocks.

How does Minerva Surgical compare to Heart Test Laboratories?

Heart Test Laboratories (NASDAQ:HSCSW) and Minerva Surgical (NASDAQ:UTRS) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, analyst recommendations, risk, profitability, valuation, earnings and dividends.

Heart Test Laboratories has higher earnings, but lower revenue than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heart Test Laboratories$8.67KN/AN/AN/AN/A
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A

Company Net Margins Return on Equity Return on Assets
Heart Test LaboratoriesN/A N/A N/A
Minerva Surgical N/A N/A N/A

In the previous week, Heart Test Laboratories had 1 more articles in the media than Minerva Surgical. MarketBeat recorded 1 mentions for Heart Test Laboratories and 0 mentions for Minerva Surgical. Heart Test Laboratories' average media sentiment score of 1.89 beat Minerva Surgical's score of 0.00 indicating that Heart Test Laboratories is being referred to more favorably in the media.

Company Overall Sentiment
Heart Test Laboratories Very Positive
Minerva Surgical Neutral

Summary

Heart Test Laboratories beats Minerva Surgical on 2 of the 3 factors compared between the two stocks.

How does Minerva Surgical compare to HeartBeam?

HeartBeam (NASDAQ:BEATW) and Minerva Surgical (NASDAQ:UTRS) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, valuation, media sentiment, earnings, dividends and risk.

In the previous week, HeartBeam had 2 more articles in the media than Minerva Surgical. MarketBeat recorded 2 mentions for HeartBeam and 0 mentions for Minerva Surgical. HeartBeam's average media sentiment score of 0.44 beat Minerva Surgical's score of 0.00 indicating that HeartBeam is being referred to more favorably in the media.

Company Overall Sentiment
HeartBeam Neutral
Minerva Surgical Neutral

HeartBeam has higher earnings, but lower revenue than Minerva Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HeartBeamN/AN/AN/AN/AN/A
Minerva Surgical$51.69M0.00-$34.11M-$4.21N/A

Company Net Margins Return on Equity Return on Assets
HeartBeamN/A N/A N/A
Minerva Surgical N/A N/A N/A

Summary

HeartBeam beats Minerva Surgical on 2 of the 3 factors compared between the two stocks.

Get Minerva Surgical News Delivered to You Automatically

Sign up to receive the latest news and ratings for UTRS and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding UTRS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

UTRS vs. The Competition

Export
MetricMinerva SurgicalSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$1K$39.45M$6.52B$12.05B
Dividend YieldN/A1.08%2.67%5.66%
P/E Ratio0.0017.8224.0024.42
Price / SalesN/A27.38514.65112.54
Price / CashN/A18.8627.4837.92
Price / BookN/A12.2810.696.82
Net Income-$34.11M-$16.77M$3.57B$337.56M

Minerva Surgical Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
UTRS
Minerva Surgical
N/AN/AN/AN/A$1K$51.69MN/A160
MOTS
Motus GI
N/AN/AN/AN/A$1K$319KN/A30
DRTSW
Alpha Tau Medical
N/A$2.00
flat		N/A+773.3%$0.00N/AN/A80
ANZUW
Anzu Special Acquisition Corp I
N/A$0.05
-19.2%		N/A+44.9%$0.00N/AN/A2
HSCSW
Heart Test Laboratories
N/A$0.06
flat		N/A-50.2%$0.00$8.67KN/A10

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:UTRS) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Is SpaceX really worth 1.78 Trillion?
With SpaceX approaching a near-$2 trillion valuation, most investors are focused on the IPO itself - but analy...
InvestPub | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
SpaceX is chump change compared to Elon’s $20T ‘iPhone’
Early Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...
StocksToTrade | Sponsoredtc pixel
The roadshow starts Monday. This stock isn't ready.
The SpaceX roadshow kicks off June 8. Goldman Sachs, the lead underwriter, will present the full S-1 to the wo...
Behind the Markets | Sponsoredtc pixel
Trump just signed it
A recent policy development is drawing attention from income-focused investors. According to one analyst, c...
Investors Alley | Sponsoredtc pixel